Design Therapeutics Inc
Biotechnology
Healthcare
DSGN
56.76 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
6.33
52 week high
7.50
high
6.40
52 week low
0.00
previous Close
6.35
P/E ratio
market cap
230 M
div yield
0
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top